Image Guided Surgery (IGS) Devices Market

Image Guided Surgery (IGS) Devices Market Outlook (2025 to 2035)

The global image-guided surgery (IGS) devices market was valued at USD 8,543 million in 2024 and is forecast to expand at a noteworthy CAGR of 8.7% to reach USD 21,386 million by 2035.

The healthcare industry operates the image-guided surgery (IGS) market, where advanced imaging systems assist surgeons in improving surgical precision. Through MRI, CT, ultrasound, and endoscopy systems, surgeons receive immediate visual information, which enhances the results of their procedures. Medical procedure equipment is widely used in neurosurgery, orthopedic surgery, cardiovascular surgery, and oncology operations.

The industry is expanding significantly due to rising MIS procedure needs, enhanced imaging system advancements, and the implementation of an AI navigation platform. The healthcare industry is moving forward due to rising chronic disease cases, rising expenses, and improved surgical technology availability.

The leading regions of North America and Europe produce the most business, while China and India function as significant growth areas due to their advancing healthcare infrastructure and increasing governmental support.

Report Attributes	Details
Image Guided Surgery (IGS) Devices Market Size (2024A)	USD 8,543 Million
Estimated Market Value (2025E)	USD 9,286 Million
Forecasted Market Value (2035F)	USD 21,386 Million
Global Market Growth Rate (2025 to 2035)	8.7% CAGR
East Asia Market Share (2025)	18.9%
China Market Growth Rate (2025 to 2035)	8.4% CAGR
Key Companies Profiled	GE Healthcare; Medtronic Plc.; Olympus Corporation; Siemens Healthineers; Koninklijke Philips N.V.; Analogic Corporation; Brainlab AG; Karl Storz Gmbh & Co. KG; Stryker Corporation; Varian Medical Systems Inc.; Ziehm Imaging; Johnson Johnson; Fujifilm Holdings; Asahi Intecc; Canon Medical Systems; Boston Scientific; Brainlab; Nikon; Carl Zeiss Meditec; Other Prominent Players.

Historic Analysis (2020 to 2024) and Future (2025 to 2035) Pathway Analysis for the image guided surgery (IGS) devices market

The image-guided surgery devices market experienced continuous growth from 2020 to 2024 due to rising surgical procedures and enhanced navigation technology advancements. During this period, the market showed two main trends.

The market sector will adopt robotic-assisted surgeries and AI-integrated navigation technologies in 2021. 2022 introduced Research & Development investments that included augmented reality (AR) and AI-based surgical planning tools as a major industry trend.

Facilities and medical device companies developed quick teamwork in 2023 to integrate real-time image-guided systems into clinical practices.

The global image-guided surgical market will expand in 2024 because of new regulatory approvals and 5G technology deployment.

• Short-term (2025 to 2028): Short-term market growth will be driven by increased hospital investment in high-precision surgical equipment and better integration of AI-based imaging systems. Furthermore, the increasing number of robot-assisted surgical operations will fuel market growth. Governments in industrialized countries are projected to expand funding for minimally invasive surgeries, boosting growth.
• Medium Term (2028 to 2032): The medium-term expansion will witness elevated usage of 3D imaging solutions, intraoperative imaging tools, and neurosurgical navigation devices. Advanced healthcare technology involving cloud-based surgical systems and real-time remote surgical assistance will significantly improve operating accuracy and patient results.
• Long-term (2032 to 2035): From 2032 to 2035, individualized surgery planning using artificial intelligence (AI), augmented reality (AR),, and virtual reality (VR) is predicted to dominate the industry. The continuous trend toward autonomous robotic surgery and wearable diagnostic imaging technologies will fuel demand. The global push for value-based healthcare and precision medicine will further transform surgical procedures.

Based on the facts mentioned above, the image-guided surgery (IGS) devices market is anticipated to grow at a CAGR of 8.7% during the forecast period from 2025 to 2035, according to Fact.MR, a market research and competitive intelligence provider.

Market Dynamics

What are the Factors Propelling Global Sales of Image Guided Surgery (IGS) Devices?

“Integration of Artificial Intelligence in Image Guided Surgery”

Implementing artificial intelligence into image-guided surgery operations enhances real-time clinical choices through precise surgery and improved risk assessment methods. AI-powered imaging systems facilitate patient care throughout each surgical phase, from planning to monitoring, which results in fewer medical mistakes and superior care results.

Implementing machine learning algorithms enables AI systems to analyze extensive datasets, which allows them to detect human anatomical details, forecast medical complications, and specify minimal invasion operation conduits.

Several companies, including Medtronic, Stryker, and Brainlab, have established funding for AI-based surgical robots that will dominate the market during the following decade. AI-enabled computer vision technology enables surgeons to perform better by enhancing their abilities to explore complex anatomical regions.

Both the da Vinci Surgical System and Mazor X robotic surgery systems entice market expansion worldwide because they integrate AI technologies. In the upcoming years, the use of AI during IGS surgeries will extend to fully automated surgical procedures, resulting in significant reductions in surgical complications and substantial efficiency improvements.

“Growing demand for minimally invasive surgery (MIS)”

Due to shorter hospital stays and lower surgical risks associated with recovery times, MIS techniques have gained momentum as a treatment standard for neurosurgical, orthopedic, and cardiovascular surgeries. This has surged the adoption rate of image-guided navigation systems used to enhance precision in minimally invasive techniques.

What are the Challenges Encountered by Manufacturers of Image Guided Surgery (IGS) Devices?

“High Cost of Image Guided Surgery Systems”

While advanced surgical technologies have become increasingly sought after, the high cost of IGS systems, especially in developing countries, keeps them out of reach. The cost of acquiring and maintaining MRI-based navigation systems, robotic-assisted surgery devices, and intraoperative imaging tools can be between USD 500,000 and over USD 2 million per unit, placing them beyond the budgets of most healthcare facilities.

Furthermore, software integration, integrated tools for AI-powered image analysis, and special surgeon training have imposed extra financial costs. Large hospitals in developed regions can afford such investments; however, smaller and mid-sized healthcare facilities are hesitant to adopt such solutions. Thus, manufacturers are working on cost-effective solutions and subscription-based models that allow small-sized healthcare providers to use these technologies with lower initial investments.

Country-wise Insights

Why is the Adoption of Image Guided Surgery (IGS) Devices High in the United States?

“Extensive Use of Industrial Robots in Production”

The market in the United States is estimated at USD 2,963 million in 2025 and is projected to expand at a CAGR of 9.5% through 2035. This market will generate a USD 4,383 million absolute opportunity from 2025 to 2035.

The U.S. continues to dominate the world market for AI-based robotic surgical systems and image-guided technologies. Companies like Intuitive Surgical, Medtronic, and Stryker Corp. further encourage innovation in real-time imaging combined with robotic precision.

The U.S. government stimulates minimally invasive surgeries by undertaking initiatives like the Medicare Innovation Center, which offers reimbursement services for complex surgical treatments, thus promoting this market.

Why is China a Lucrative Market for Image Guided Surgery (IGS) Devices Manufacturers?

“Entry of Domestic Players in the Market”

With enormous investments in healthcare digitization and smart hospitals, China is well on its way to becoming a key player in the IGS market. Government initiatives such as "Healthy China 2030" encourage hospitals to adopt AI-driven imaging solutions.

Chinese medical technology companies, such as Midea Group, MicroPort Medical, and United Imaging Healthcare, are investing heavily in cost-effective imaging navigation systems, further increasing competition in the global IGS market.

Category-wise Insights

Which Application type Holds Largest Market Share in the Image Guided Surgery (IGS) Devices?

“Image-guided surgical technology operates as a revolution in neurosurgical techniques which produces better medical results for patients”

Demand for neurosurgery image-guided surgery (IGS) devices is projected to grow at a CAGR of 8.6% from 2025 to 2035. Neurosurgical procedures benefit most from Image Guided Surgery (IGS) because they require exact precision to operate on the brain and spinal area. Both improved surgical accuracy and decreased procedural risks result from the requirement to use real-time imaging with navigation systems in complex neurosurgical operations.

MRI-guided neuronavigation, CT-based stereotactic surgery, and intraoperative ultrasound imaging allow surgeons to view brain structures in 3D while tracking live movements to protect vital structures during procedures. Artificial Intelligence (AI) and augmented reality (AR) enhance surgical precision through better procedural outcomes and reduced operative durations and postoperative problems.

Deep brain stimulation (DBS) procedures, tumor removals, and epilepsy surgeries benefit from robotic-assisted neurosurgery equipment, which provides precise microscopic capabilities. The system uses AI technology to create surgical route simulations, which help surgeons prevent injuries to important body parts.

The global rise of neurodegenerative diseases alongside brain tumors and traumatic brain injuries will result in sustained growth of high-precision and minimally invasive neurosurgical techniques. Both autonomous robotic surgery development and 5G technology expansion for remote procedures will shape the future of IGS neurosurgery because they provide worldwide access to medical expertise.

What drives hospitals' overwhelming use of image-guided surgery technologies and creates substantial value for the entire healthcare system?

“Hospitals Advanced Infrastructure and Increased Surgical Procedure Volume”

Hospitals account for 46.7% of the market share in 2025. Hospitals' financial abilities make high-end IGS systems that can reach millions in price accessible. Hybrid operating rooms within advanced hospitals unite IGS elements with robotic technology and intelligent navigation systems to enable minimally invasive, complex surgical procedures. Exterior facilities combine to give patients optimal surgical results while minimizing their required hospital duration and surgical complications.

Implementing robotic-assisted image-guided surgical procedures has put hospitals at the forefront of neurosurgical, orthopedic, and oncological fields. AI-powered analytics allow healthcare providers to create individualized treatment plans and identify potential outcomes through predictive analytics, leading to better decision-making.

Hospitals will be essential in fueling market advancement due to the worldwide transition to precision medicine and value-based healthcare initiatives. Due to advancing technology, hospital-based IGS will experience revolutionary changes by implementing cloud-based imaging systems and 5G-powered remote surgeries.

Competitive Landscape

Key players in the image guided surgery (IGS) devices market are GE Healthcare, Medtronic Plc., Olympus Corporation, Siemens Healthineers, Koninklijke Philips N.V., Analogic Corporation, Brainlab AG, Karl Storz Gmbh & Co. KG, Stryker Corporation, Varian Medical Systems Inc., Ziehm Imaging, Johnson and Johnson, Fujifilm Holdings, Asahi Intecc, Canon Medical Systems, Boston Scientific, Brainlab, Nikon, Carl Zeiss Meditec.

Companies devote a significant portion of their revenue to R&D to resolve problems and offer creative solutions to draw in new customers and stay competitive. Companies are developing customized offerings for issues that meet industry-specific needs to compete with other players.

• Medtronic introduces AI-powered surgical navigation system in March 2024 improving precision in minimally invasive surgeries
• Stryker expands image-guided robotics portfolio in January 2024, introducing next-gen platforms with enhanced intraoperative imaging capabilities.

In the recently published report, Fact.MR provided detailed information about the price points of key image-guided surgery (IGS) device manufacturers positioned across regions, sales growth, production capacity, and speculative technological expansion.

Segmentation of Image Guided Surgery (IGS) Devices Industry Research

• By Product Type :

  • Image Guided Surgery Devices
    • CT Scanners
    • Ultrasound Systems
    • MRI System
    • Endoscopes
    • X-ray Fluoroscopy Devices
    • Positron Emission Computed Tomography (PET) Devices
    • Single Photon Emission Computed Tomography (SPECT) Devices
  • Image Guided Surgery Software

• By Application :

  • Neurosurgery
  • Orthopedic Surgery
  • Cardiac Surgery
  • Oncology Surgery
  • Others (ENT, Dental, Pulmonary Surgery)

• By End User :

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Specialty Clinics
  • Academic & Research Institutes
  • Others

• By Region :

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa